Happy Monday! Washington is kicking off the week with a heavy dose of health policy activity, as federal funding decisions, Medicaid implementation challenges, and election-year messaging all converge. Secretary Kennedy is set to face lawmakers on Capitol Hill while continuing to push a prevention-first agenda, even as Congress signals resistance on key funding priorities. At the same time, states are grappling with the real-world strain of new Medicaid requirements, and industry stakeholders are watching affordability once again take center stage politically. Here’s what to know heading into the week.

• Federal:

  • RFK Jr. congressional hearings, drug pricing focus in Senate HELP, research funding tensions, HHS priorities

• State:

  • Medicaid work requirements implementation challenges, state staffing and eligibility pressures, Arizona as a prevention policy focal point

• Industry:

  • Health care affordability and 2026 election dynamics, Medicare Advantage / dual-eligible policy gaps, Federal modernization and health IT signals

WHO’S HAVING EVENTS THIS WEEK?

Tuesday, April 14th

• House Ways & Means Health Subcommittee: “Field Hearing on Modernized Health Care in Practice: Empowering Americans to Live Healthier Lives” at 9 am in Bradenton, FL. Watch here.

Wednesday, April 15th

• *House Energy & Commerce Subcommittee on Health: “Healthier America: Legislative Proposals to Improve Public Health” at 10:15 am. Watch here.

Thursday, April 16th

• *House Ways & Means: “Hearing with Health and Human Services Secretary Robert F. Kennedy, Jr.” at 9 am. Watch here.

• *Senate HELP: “Hearings to examine making medicines more affordable, focusing on how competition can lower drug prices” at 10 am. Watch here.

• *House Appropriations Labor-HHS-Education Subcommittee: “Budget Hearing – Department of Health and Human Services“ at 2 pm. Watch here.

Friday, April 17th

• House Committee on Education & Workforce: “Examining the Policies and Priorities of the Department of Health and Human Services” at 9 am. Watch here.

*Will be covered by Nimitz Health. Please email [email protected] if you would like a readout of any other hearings.

Sign up for The Nimitz Report for Veteran Health-Related Hearings

NEWS DRIVING THE WEEK

Federal News

Washington’s health agenda continues to be shaped by Secretary Kennedy’s prevention-focused “Make America Healthy Again” push, with HHS using this week to highlight both policy messaging and concrete funding announcements. The clearest federal action item was HRSA’s announcement of more than $135 million to expand nutrition services in primary care and support new rural residency programs, a sign the administration is tying chronic disease prevention and workforce development more closely together. At the same time, Kennedy used an Arizona swing to reinforce the administration’s emphasis on prevention, recovery, and tribal engagement, underscoring how HHS is trying to frame its broader health agenda around nutrition, fitness, and local delivery systems rather than traditional federal program debates.

Congressional engagement will be front and center this week, with Kennedy scheduled to appear twice on Capitol Hill. He is set to testify before the House Ways & Means Committee in a broad oversight hearing, and again before the House Appropriations Labor-HHS-Education Subcommittee for a budget-focused hearing—both of which are expected to probe funding priorities, program direction, and implementation of the administration’s agenda. In parallel, the Senate HELP Committee will hold a hearing on prescription drug affordability, with a focus on how competition can lower prices, signaling continued bipartisan interest in cost containment even as broader health reform debates remain unsettled.

Another notable storyline is the administration’s effort to control the public narrative around health policy. Kennedy’s planned launch of a new podcast reflects a more direct-to-audience communications strategy centered on chronic disease, nutrition, and government “transparency.” Meanwhile, the confirmation path for Surgeon General nominee Casey Means remains uncertain, highlighting that personnel politics at the top of HHS are still in flux.

Federal budget pressure remains a major undercurrent. Reporting indicates continued White House interest in cutting medical research spending, even as Congress has shown resistance to deep NIH reductions. For health stakeholders, that tension reinforces that while the administration’s appetite for retrenchment persists, congressional appropriators remain a meaningful counterbalance.

State News

At the state level, the biggest near-term operational issue remains Medicaid work requirements. New reporting shows many state Medicaid agencies are already stretched on eligibility processing and call-center capacity, and officials in several states say they will need more staff to implement the new requirements effectively. That matters because the burden is not just the work-rule checks themselves; states will also face more frequent eligibility verifications, raising the risk of administrative churn and coverage losses even where demand for coverage remains high.

Arizona also stood out this week as a proving ground for the administration’s prevention-first message. HHS used the state to spotlight local recovery, primary care, and tribal-health priorities, while connecting those themes to federal funding already flowing through behavioral health and related programs. For states, the signal is that alignment with prevention, rural access, and workforce development priorities may position them well for future federal support.

Industry News

For the health care industry, affordability is quickly re-emerging as the issue most likely to shape both politics and business strategy in 2026. New analysis shows health care costs are a top concern for voters, with Democrats currently holding an edge on trust to manage costs, but a large share of voters, particularly independents, remain unconvinced by either party. That dynamic keeps pricing, premiums, and drug costs squarely in focus for plans, providers, and manufacturers alike.

Medicare Advantage policy continues to create uncertainty for organizations serving dual eligibles. A recent analysis suggests CMS’s revised “look-alike” plan termination policy has not gone far enough to shift enrollment into fully integrated models, leaving many beneficiaries in fragmented coverage arrangements. For insurers and providers, that signals ongoing complexity in product design and care coordination for high-need populations.

FOR FUN

Join the military and veteran community in DC for HillVets Happy Hour this Thursday, from 5:30-7:30!

JOIN THE NIMITZ NETWORK!

Enjoying our updates? Don’t keep it to yourself — forward this email to friends or colleagues who’d love to stay informed. Please subscribe to our other publications by clicking below: